EU-PhD position entitled: The role of osteoclasts in osteoarthritic pain, is available as a collaboration between Nordic Bioscience and the University of Copenhagen (members of the BONEPAIN consortium).
Nordic Bioscience was established in 1992 and has two divisions.
The Biomarker & Research division, with offices in Herlev, Denmark, has focus on developing novel biochemical markers for the diagnosis and prognosis of major human diseases. These biomarker panels are fully integrated into drug development programmes to accelerate speed and increase the likelihood of success. The Division’s executive team includes PhDs with many years of experience in biochemical development and clinical research and has a total of 100 fully dedicated employees of which 62 are directly involved in R&D.
Our primary therapeutic indications are Osteoporosis, Osteoarthritis, Weight-loss, CVD, Diabetes and Alzheimer’s.
We are now looking for a PhD student to assist the Musculoskeletal disorders team.
In vitro and in vivo assessment of osteoclast activity in both healthy and osteoarthritic conditions.
Studies of the effects of pharmacotherapies addressing osteoclast function and pain, as well as structure of both cartilage and bone.
Master’s degree in biochemistry, biology, biotechnology or something similar. It is preferable, but not mandatory if you are familiar with animal handling, cell lab work and immunological methods.
You must be in the first four years of your research career. The four years are counted from the date the degree which formally entitles them to embark on a doctorate was obtained.
You must not have resided or carried out your main activity (work, study, etc.) in Denmark for more than 12 months in the 3 years immediately prior to the time of recruitment
We offer you a challenging and exciting job in a team consisting of 5 scientists, and additionally you will be part of the international network BONEPAIN.
Please send your motivated application, academic certificate, references and CV to
Head of Musculoskeletal Diseases
Nordic Bioscience Biomarkers and Research
Nordic Bioscience has more than 20 years’ experience in biomarker research, primarily within the area of the slow and chronic degenerative diseases of osteoporosis, osteoarthritis, fibrosis and cardiovascular diseases. Nordic Bioscience expects to deliver the next generation of unique and clinically superior in vitro disease-specific diagnostic products. Please visit our website at www.nordicbioscience.com.